- CSL Behring
- King of Prussia, Pennsylvania
- Start date
- Mar 23, 2023
- Marketing, Market Access
- Required Education
- Bachelors Degree
- Position Type
- Full time
- Pharm Country, Best Places to Work
The Vice President GEMAP is responsible for the development of global market access strategies, global evidence plans and generation including health economics and outcomes research and global pricing strategies for the entire CSL Behring portfolio, both in-line and pipeline. These key strategies are developed in alignment with global business objectives during development, launch and life cycle management of the portfolio. This position ensures ongoing assessment and adaption of strategies to maintain an optimal portfolio and market access and works collaboratively with the Therapeutic Area (TA) Commercial Co-leads as well as the regional heads of NA/EU/APAC/ICO and with Global Healthcare Policy & External Affairs to ensure smooth cooperation between HQ and our regional colleagues.
Develops global market access strategies and ongoing assessment and adaption of strategies from product development through launch and life cycle management including pricing, reimbursement, value proposition and messaging, evidence generation and payer strategies. Monitors trends and developments in order to proactively identify needs and actions to support the value proposition of our portfolio across a multitude of payer environments.
Ensures integration of market access and payer perspectives into product development plans at all stages of development in close collaboration with R&D and in accordance with the Stage Gate system.
Provide overall product value demonstration strategies and evidence generation including maximization of health economics, HTA and quality of life outcomes and development of global value dossiers.
Develops global pricing strategies and ongoing assessment and adaptation of strategies to ensure an optimal balance of revenue, volume, margin and access across the portfolio and geographies.
Provides global oversight and support for the affiliates in fulfilling their market access ambitions, achieving optimal pricing and revenue for CSL Behring products, and maintaining reimbursement and access in the context of the evolving Market Access landscape and increasing access restrictions by payers.About Us
We encourage you to make your well-being a priority. It’s important and so are you. Learn more about how we care at CSL.
About CSL Behring
CSL Behring is a global leader in developing and delivering high-quality medicines that treat people with rare and serious diseases. Our treatments offer promise for people in more than 100 countries living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. Learn more about CSL Behring.
We want CSL to reflect the world around us
As a global organisation with employees in 35+ countries, CSL embraces diversity, equity and inclusion. Learn more about Diversity, Equity & Inclusion at CSL.
Do work that matters at CSL Behring!
As the third largest global biotechnology company with employees in more than 35 countries, CSL Behring is focused on serving patients with serious and rare diseases, including coagulation disorders, primary immune deficiencies, hereditary angioedema, respiratory disease and neurological disorders. We collaborate with patient and biomedical communities to improve access to therapies, advance scientific knowledge and support future medical research.
CSL Behring's dynamic environment fosters innovation and attracts the best and brightest who share a commitment to helping save lives. People here are free to live their Promising FUTURES where they can fulfill their individual career aspirations and realize their potential.
CSL Behring is committed to diversity and inclusion, both of which underpin our Values of patient focus, innovation, collaboration, integrity and superior performance. We believe that by harnessing and honoring the unique capabilities, experiences and perspectives of our people, we are better able to serve our patients.
CSL Behring operates one of the world's largest plasma collection networks, CSL Plasma. The parent company, CSL Limited, headquartered in Melbourne, Australia, employs more than 27,000 people, and provides its life-saving medicines in more than 70 countries.
For more information visit www.cslbehring.com. Help us deliver on our promise to save lives and protect the health of people around the world. Promising FUTURES start at CSL Behring!
Stock Symbol: CSL
Stock Exchange: Australian Securities Exchange
1020 First Avenue
King of Prussia
Get job alerts
Create a job alert and receive personalized job recommendations straight to your inbox.Create alert